AMSA Convention 2016 Logo

The Trans-Pacific Partnership Agreement for Physicians-in-Training

The Trans-Pacific Partnership Agreement (TPP) is a multilateral free trade agreement being negotiated in secret between the United States and countries in the Asia-Pacific and South America including Canada and Mexico. According to the United States Trade Representative, this agreement will "set the standard for 21st-century trade agreements going forward". From leaked text, it is clear that the United States is pushing aggressive provisions that would limit access to life-saving generic medications through enhanced patent protections and data exclusivity favoring brand-name pharmaceutical companies. Other concerning provisions also threaten the principles of evidence-based medicine as practitioners will be forced to choose not necessarily the best treatments for their patients due to fear of patent infringement for diagnostic, therapeutic, and surgical methods. Additionally, as provisions for tobacco and alcohol are not excluded from the TPP, multinational companies will potentially be allowed to override national initiatives to curb access to such products and prevent millions of disease and death that these products cause.

If the TPP is finalized with these provisions included, millions of people around the world will not be able to access affordable medicines, receive the best treatment available, or be prevented through government initiatives from admirable goals such as becoming "smokefree" or curbing alcohol abuse.


AMSA TPP Advocacy

External TPP Resources

TPP Negotiations

Pharmfree Fellow, Reshma Ramachandran, presenting at 14th Round of TPP Negotiations, Leesburg, VA, Sept 2012.

Alison Case, Elizabeth Wiley and Reshma Ramachandran at 14th Round of TPP Negotiations, Leesburg, VA, Sept 2012.

National President, Elizabeth Wiley, tabling at 14th Round of TPP Negotiations, Leesburg, VA, Sept 2012.